VolitionRx Limited (VNRX)

USD 0.48

(-2.45%)

EBITDA Summary of VolitionRx Limited

  • VolitionRx Limited's latest annual EBITDA in 2023 was -34.04 Million USD , down -18.27% from previous year.
  • VolitionRx Limited's latest quarterly EBITDA in 2024 Q1 was -8.06 Million USD , up 3.65% from previous quarter.
  • VolitionRx Limited reported an annual EBITDA of -29.23 Million USD in 2022, down -13.92% from previous year.
  • VolitionRx Limited reported an annual EBITDA of -25.68 Million USD in 2021, down -31.46% from previous year.
  • VolitionRx Limited reported a quarterly EBITDA of -6.66 Million USD for 2024 Q2, up 17.56% from previous quarter.
  • VolitionRx Limited reported a quarterly EBITDA of -8.48 Million USD for 2023 Q1, down -21.77% from previous quarter.

Annual EBITDA Chart of VolitionRx Limited (2023 - 2004)

Historical Annual EBITDA of VolitionRx Limited (2023 - 2004)

Year EBITDA EBITDA Growth
2023 -34.04 Million USD -18.27%
2022 -29.23 Million USD -13.92%
2021 -25.68 Million USD -31.46%
2020 -19.22 Million USD -29.54%
2019 -15.07 Million USD 12.69%
2018 -17.25 Million USD -21.83%
2017 -14.15 Million USD -22.18%
2016 -11.59 Million USD -16.4%
2015 -9.96 Million USD -208.32%
2014 -8.07 Million USD -12.83%
2013 -3.56 Million USD 27.45%
2012 -3.94 Million USD -58.54%
2011 -13.02 Thousand USD -22644.55%
2010 -10.94 Thousand USD 30.79%
2009 -15.81 Thousand USD 27.46%
2008 -21.8 Thousand USD 17.08%
2007 -26.29 Thousand USD 28.91%
2006 -36.98 Thousand USD -182.24%
2005 -13.1 Thousand USD 45.8%
2004 -24.18 Thousand USD 0.0%

Peer EBITDA Comparison of VolitionRx Limited

Name EBITDA EBITDA Difference